Strata Critical Medical, Inc. Class A Common Stock (SRTA) Q2 2024 Earnings
Strata Critical Medical, Inc. Class A Common Stock reported Q2 2024 revenue of $67.9M, beat analyst consensus of $63.1M by $4.8M. Diluted EPS came in at $-0.06.
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Strata Critical Medical, Inc. Class A Common Stock's Q2 2024 earnings report.
Strata Critical Medical, Inc. Class A Common Stock (SRTA) reported Q2 2024 earnings on August 7, 2024 after market close.
Strata Critical Medical, Inc. Class A Common Stock reported revenue of $67.9M and diluted EPS of $-0.06 for Q2 2024.
Revenue beat the consensus estimate of $63.1M by $4.8M. EPS beat the consensus estimate of $-0.06 by $0.00.
You can read the 10-Q periodic report (0001779128-24-000097) directly on SEC EDGAR. The filing index links above go to sec.gov.